Brief: Monopar Therapeutics Files Prospectus Relates To Resale From Time To Time Of Up To 705,015 Shares Of Common Stock By Selling Stockholder
29/11/2024 23:15
Nov 29 (Reuters) - Monopar Therapeutics Inc MNPR.O :
* MONOPAR THERAPEUTICS FILES PROSPECTUS RELATES TO RESALE
FROM
TIME TO TIME OF UP TO 705,015 SHARES OF COMMON STOCK BY SELLING
STOCKHOLDER
Source text: ID:n0001437749-24-036380
Further company coverage: MNPR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Monopar Therapeutics
See all newsBrief: Monopar Appoints Jeffrey D. Kent, M.D., As Executive Vice President, Head Of Medical Affairs Announces Two Alxn1840 Presentations At Aasld – The Liver Meeting 2026
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Monopar Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Monopar Therapeutics Inc. expected to post a loss of 62 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Alphabet, IBM, Tesla